Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

59.75USD
7:34pm GMT
Change (% chg)

$-3.63 (-5.73%)
Prev Close
$63.38
Open
$62.98
Day's High
$63.78
Day's Low
$58.12
Volume
16,793
Avg. Vol
32,340
52-wk High
$76.98
52-wk Low
$34.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.02 -0.547
Mar '18 0.03 -1.069
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.26 1.14 0.00 0.77
Quarter Ending Mar-19 1 0.00 0.00 0.00 0.40
Year Ending Dec-18 7 1.20 5.00 0.00 2.57
Year Ending Dec-19 6 1.78 10.00 0.00 2.17
Earnings (per share)
Quarter Ending Dec-18 6 -1.13 -0.80 -1.30 -0.68
Quarter Ending Mar-19 1 -0.97 -0.97 -0.97 -0.80
Year Ending Dec-18 7 -3.72 -3.09 -4.13 -2.71
Year Ending Dec-19 6 -3.98 -1.35 -5.29 -3.20
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.81 45.61
P/E Low - Last 5 Yrs. -- 85.16 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) 367.07 121.72 5.95
Price to Book (MRQ) 7.85 14.77 4.89
Price to Tangible Book (MRQ) 9.04 13.90 6.50
Price to Cash Flow (TTM) -- 66.82 22.90
% Owned Institutions 64.55 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.42
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -60.92 387.09 8.08
Sales (TTM) vs TTM 1 Yr. Ago -53.33 97.69 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -79.01 27.93 23.28
EPS (TTM) vs TTM 1 Yr. Ago -40.57 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 8.54 5.29 3.07
LT Debt to Equity (MRQ) 0.00 36.70 13.15
Total Debt to Equity (MRQ) 0.00 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -2,898.05 -- --
EBITD - 5 Yr. Avg -- -554.61 10.90
Operating Margin (TTM) -2,920.87 -797.52 3.24
Operating Margin - 5 Yr. Avg. -- -575.60 6.22
Pre-Tax Margin (TTM) -2,993.16 -760.66 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -580.99 6.66
Net Profit Margin (TTM) -2,990.32 -761.51 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.63 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 35,176 22,793,730 803,345,227
Net Income/Employee (TTM) -1,051,866 1,402,844 94,482,509
Receivable Turnover (TTM) 7.19 19.91 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) 0.02 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.87 -1.67 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -83.31 -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -83.31 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.98 21.63 99 58
13 Week 27.10 20.91 99 61
26 Week 30.62 20.69 99 74
52 Week 78.77 51.52 99 45
YTD 76.83 55.29 99 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.75%
# of Holders: 118
Total Shares Held: 39,644,359
3 Mo. Net Change: -99,244
# New Positions: 4
# Closed Positions: 6
# Increased Positions: 14
# Reduced Positions: 14
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.